However, this effect appears to be cell/cancer-type specific, as the over-expression of PRMT6 in human estrogen-sensitive breast cancer cells (MCF7) and the human prostate cancer cells (PC3) increases the TSP-1 expression and hence inhibits the movement and invasion of cancer cells [86]. The gene discussed is PRMT6; the disease is prostate carcinoma.